ResearcherTaipei Medical UniversityActive in the last 2 years

Dahlak Daniel Solomon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1836-733X; OpenAlex author ID A5009050600. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12967-026-07865-0 ↗
A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc validation via single-cell transcriptomics. Co-author DOI 10.1093/bib/bbaf583 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ngoc Uyen Nhi Nguyen · 1 shared paper, 2025 · strength 0.22
- Paper A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc val… DOI 10.1093/bib/bbaf583 ↗
Pei‐Ming Yang · 1 shared paper, 2025 · strength 0.22
- Paper A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc val… DOI 10.1093/bib/bbaf583 ↗
Jaqueline Whang-Peng · 1 shared paper, 2026 · strength 0.22
- Paper Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic … DOI 10.1186/s12967-026-07865-0 ↗
Zilin Li · 1 shared paper, 2026 · strength 0.22
- Paper Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic … DOI 10.1186/s12967-026-07865-0 ↗
Ching‐Chung Ko · 1 shared paper, 2026 · strength 0.22
- Paper Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic … DOI 10.1186/s12967-026-07865-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.